Apomorphine Hydrochloride USP For Compounding (API) (Rx)

Apomorphine hydrochloride USP is an active pharmaceutical ingredient (API) used in the formulation of medications and drugs for the treatment of Parkinson's disease. It belongs to a class of drugs called dopamine agonists, which work by mimicking the action of dopamine (a neurotransmitter) in the brain. This helps to improve motor function and reduce symptoms such as tremors, stiffness, and slowness of movement. Apomorphine hydrochloride is a synthetic derivative of morphine and is typically administered via injection or sublingual (under the tongue) tablets.

Apomorphine hydrochloride is a medication that is used in compounding to treat problems associated with Parkinson's disease, such as muscle stiffness, tremors, and difficulty with movement. It mimics the actions of dopamine in the brain and helps to regulate movement and coordination. In compounding, it can be used to make individualized medications for patients who are unable to take standard Parkinson's disease medications due to side effects or allergies.